中文名稱:pcDNA4/TO/myc-His B 載體 | 英文名稱:pcDNA4/TO/myc-Hi |
保存條件: 常溫運輸 | 純度規(guī)格: 99% |
產(chǎn)品類別: 質粒/載體 |
A Tetracycline-Regulated Expression System without Viral Transactivators
The T-REx™ System yields higher levels of induced expression than any other regulated mammalian expression system. It utilizes the complete CMV promoter and adds control elements from the bacterial tetracycline resistance operon to effectively repress and derepress transcription from one of the strongest mammalian promoter sequences known (1,2).
Specific Activation
The T-REx™ System uses a repressor mechanism that blocks transcription from the powerful CMV promoter in the absence of tetracycline. Because the T-REx™ System elements do not use viral transactivators, you can achieve high-level expression from the complete CMV promoter without secondary, non-specific activation of host genes.
The T-REx™ Mechanism
The T-REx™ transcriptional control elements are illustrated in Figure 1. Two tetracycline operator sequences (TetO2) have been inserted between the TATA box of the CMV promoter and the
特別提示:本公司的所有產(chǎn)品僅可用于科研實驗,嚴禁用于臨床醫(yī)療及其他非科研用途!
成立日期 | 2016-08-08 (9年) | 注冊資本 | 100萬元整 |
員工人數(shù) | 1-10人 | 年營業(yè)額 | ¥ 100萬以內 |
主營行業(yè) | 生物化工,有機原料,化學試劑,醫(yī)藥原料,技術服務 | 經(jīng)營模式 | 貿易,試劑,定制,服務 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
VIP4年
|
上海冠導生物工程有限公司
|
2024-11-17 | |
¥1600.00 |
VIP9年
|
北京索萊寶科技有限公司
|
2024-11-16 | |
¥888 |
VIP6年
|
上??道噬锟萍加邢薰?/div>
|
2024-11-15 |